Cargando…

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal

BACKGROUND: Japanese encephalitis (JE) is a mosquito-borne disease that is associated with considerable morbidity and mortality in many Asian countries. The objective of this study was to describe the impact of the JE immunization program using SA 14-14-2 JE vaccine implemented in Nepal during 2006...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upreti, Shyam Raj, Lindsey, Nicole P., Bohara, Rajendra, Choudhary, Ganga Ram, Shakya, Sushil, Gautam, Mukunda, Giri, Jagat Narain, Fischer, Marc, Hills, Susan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608168/ https://www.ncbi.nlm.nih.gov/pubmed/28934197 http://dx.doi.org/10.1371/journal.pntd.0005866

Ejemplares similares

Japanese Encephalitis in Hill and Mountain Districts, Nepal
por: Bhattachan, Anuj, et al.
Publicado: (2009)

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14
por: Huang, Rong, et al.
Publicado: (2019)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
por: Liu, Xinyu, et al.
Publicado: (2018)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
por: Li, Shi-Hua, et al.
Publicado: (2013)

Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone
por: Li, Guohua, et al.
Publicado: (2021)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal
por: Wallace, Aaron S., et al.
Publicado: (2017)

The Infection of the Japanese Encephalitis Virus SA14-14-2 Strain Induces Lethal Peripheral Inflammatory Responses in IFNAR Deficiency Mice
por: Liu, Juan, et al.
Publicado: (2022)

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
por: Kwon, Hyo Jin, et al.
Publicado: (2015)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
por: Yang, Jian, et al.
Publicado: (2017)

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area
por: Turtle, Lance, et al.
Publicado: (2017)

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
por: Kim, Dong Soo, et al.
Publicado: (2014)

Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain
por: Zheng, Xiaoyan, et al.
Publicado: (2020)

T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine
por: Wang, Ran, et al.
Publicado: (2020)

The Spatial Heterogeneity between Japanese Encephalitis Incidence Distribution and Environmental Variables in Nepal
por: Impoinvil, Daniel E., et al.
Publicado: (2011)

Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
por: Turtle, Lance, et al.
Publicado: (2019)

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
por: Yun, Sang-Im, et al.
Publicado: (2014)

Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2016)

Correction: A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
Publicado: (2014)

Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain
por: Sarkar, Arindam, et al.
Publicado: (2013)

Factors associated with health facility delivery among reproductive age women in Nepal: an analysis of Nepal multiple indicator cluster survey 2019
por: Thapa, Naba Raj, et al.
Publicado: (2022)

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
por: Zaman, K., et al.
Publicado: (2022)

Isolation of 1,4‐Diarsinine‐1,4‐diide and 1,4‐Diarsinine Derivatives
por: Rottschäfer, Dennis, et al.
Publicado: (2021)

Stunting in Nepal: looking back, looking ahead
por: Devkota, Madhu Dixit, et al.
Publicado: (2016)

Adapting Nepal’s polio eradication programme
por: Paudel, Krishna P, et al.
Publicado: (2017)

Spatio-temporal epidemiology of Japanese encephalitis in Nepal, 2007-2015
por: Kumar Pant, Dhan, et al.
Publicado: (2017)

Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal
por: Ansari, Shamshul, et al.
Publicado: (2015)

Association of nutrition knowledge, practice, supplement use, and nutrient intake with strength performance among Taekwondo players in Nepal
por: Sunuwar, Dev Ram, et al.
Publicado: (2022)

Anti Japanese encephalitis virus IgM positivity among patients with acute encephalitic syndrome admitted to different hospitals from all over Nepal
por: Bhattarai, Anupama, et al.
Publicado: (2017)

Behcet's disease in an adult male from Nepal: A case report
por: Basnet, Madan, et al.
Publicado: (2021)

Pathways to mental health care in Nepal: a 14-center nationwide study
por: Gupta, Anoop Krishna, et al.
Publicado: (2021)

COVID-19 vaccination up-take in three districts of Nepal
por: Pokhrel, Tara Nath, et al.
Publicado: (2023)

Comparative Spatial Dynamics of Japanese Encephalitis and Acute Encephalitis Syndrome in Nepal
por: Robertson, Colin, et al.
Publicado: (2013)

Survey on the prevalence of intestinal parasites in domestic cats (Felis catus Linnaeus, 1758) in central Nepal
por: Adhikari, Roshan Babu, et al.
Publicado: (2022)

Employment preferences of obstetricians and gynecologists to work in the district hospitals: evidence from a discrete choice experiment in Nepal
por: Gautam, Bishnu, et al.
Publicado: (2019)

Spectrum of Injury Presenting to Emergency Department in A Tertiary Care Hospital in Nepal: A Descriptive Cross-sectional Study
por: Thapa, Sameer, et al.
Publicado: (2020)

Cannabis Use and Abuse in Nepal: A Review of Studies
por: Shakya, Dhana Ratna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5inf7cqft9o9nhvbjfj0o65oio